本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lexaria Bioscience Corp

0.6599
+0.00010.02%
成交量:3.53万
成交额:2.34万
市值:1,642.32万
市盈率:-1.17
高:0.6899
开:0.6600
低:0.6200
收:0.6598
52周最高:1.90
52周最低:0.4600
股本:2,488.74万
流通股本:2,345.37万
量比:0.44
换手率:0.15%
股息:- -
股息率:- -
每股收益(TTM):-0.5629
每股收益(LYR):-0.6613
净资产收益率:-155.23%
总资产收益率:-82.96%
市净率:3.34
市盈率(LYR):-1.00

数据加载中...

2026/02/06

重要事件披露

Form 8-K - Current report
2026/01/28

重要事件披露

Form 8-K - Current report
2026/01/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/14

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/01/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/12/17

重要事件披露

Form 8-K - Current report
2025/12/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/11/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/10/14

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/09/29

重要事件披露

Form 8-K - Current report
2025/09/25

重要事件披露

Form 8-K - Current report
2025/07/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/13

重要事件披露

Form 8-K - Current report
2025/04/28

重要事件披露

Form 8-K - Current report
2025/04/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/05

重要事件披露

Form 8-K - Current report
2025/01/28

SEC问询函

Form CORRESP - Correspondence
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/01/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans